Understanding the Link Between Immunity and Mood
Depression remains a leading cause of disability worldwide, impacting emotional well-being, everyday activities, and social relationships. One troubling symptom is anhedonia—the reduced ability to experience pleasure or interest in things previously enjoyed. While causes are not fully understood, growing evidence points toward a potential link with inflammation.
Inflammation is the immune system's natural response to infections and injuries. It can also influence how the brain processes emotions, motivation, and rewards. Researchers differentiate between "wanting" (motivation to pursue rewards) and "liking" (pleasure experienced when receiving them). Positive social interactions play a vital role in psychological well-being, prompting a team of researchers to test how acute inflammation affects social reward processing.
Inside the Clinical Trial
Led by Chloe C. Boyle and colleagues at the Norman Cousins Center for Psychoneuroimmunology at the University of California, Los Angeles, researchers conducted a double-blind, placebo-controlled trial. The study focused on healthy women between 25 and 44 years of age from the Los Angeles area, as women are particularly vulnerable to depression and related mood shifts.
Participants had no current psychiatric illness, did not smoke, and took no antidepressants or immune-affecting medications. A portion of the participants received a low dose of endotoxin through an intravenous injection to trigger a short-lived inflammatory response, while others received a saline solution placebo.
Participants provided blood samples and reported physical symptoms hourly. Two hours post-injection, around the peak of the inflammatory response, they completed tasks measuring sensitivity to positive social cues, social motivation, and anhedonia questionnaires.
Key Findings on Pleasure and Social Motivation
Two hours after the injection, women who received endotoxin reported higher levels of anhedonia and a decreased desire to chat with another person compared to the placebo group. Interestingly, the drop in motivation appeared specific to social activity; endotoxin did not significantly alter interest in doing puzzles, watching film clips, or sitting quietly. These effects persisted even after researchers accounted for physical sickness and fatigue.
The increase in anhedonia was temporary, returning to original levels four hours post-injection despite elevated inflammatory markers. Furthermore, larger increases in the inflammatory protein TNF-alpha during the first hour correlated with larger increases in anhedonia and sharper drops in the desire to chat.
Effects on sensitivity to smiling faces were more limited. The endotoxin group did not show the slight improvement in recognizing happy faces that the placebo group exhibited on a second test, though the authors noted this should be interpreted with caution due to baseline differences. Endotoxin had no effect on attentional bias.
Study Limitations to Consider
The authors noted several limitations. The study sample was small and consisted exclusively of women aged 25 to 44, meaning findings may differ for men and other age groups. Additionally, endotoxin triggers a brief, intense inflammatory response distinct from the persistent, lower-level inflammation seen in clinical depression. Social motivation was also measured via self-reported questionnaires rather than direct observation of social contact.